Study on the Administration of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Non-Diabetic Obese Patients

JRCT ID: jRCT1051240189

Registered date:18/11/2024

Basic Information

• Recruitment status: Pending
• Health condition(s) or Problem(s) studied: Obesity
• Date of first enrollment: 18/11/2024
• Study type: Observational

Outcome(s)

Primary Outcome

Body Weight
BMI: Body Mass Index (BMI)
Body Fat Percentage

• Secondary Outcome: subjective symptoms, etc.

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable

Include criteria

**Patient Selection Criteria**

**Eligibility Criteria:**
1. Individuals who did not achieve satisfactory results with standard treatments for obesity and overweight in non-diabetic patients.
2. Individuals who prefer not to undergo standard pharmacological treatments due to concerns about side effects or other reasons.

**Application Criteria:**
1. Individuals with HbA1c levels of 6.4% or below.
2. Individuals with a BMI of 25 or higher.
3. Individuals aged 18 years or older.
4. Individuals with the capacity to provide informed consent.
5. Individuals who receive a detailed explanation of the treatment, along with the consent form, and provide written consent of their own free will.
6. Individuals whose attending physician deems the treatment necessary.

Exclude criteria

"<Exclusion Criteria>
Individuals meeting any of the following conditions will be excluded from the study:
1. Users of narcotics or stimulants.
2. Individuals deemed inappropriate by the attending physician"

Related Information

• Primary Sponsor: Takashi Hirayama